SynAct Pharma AB's total assets for Q1 2025 were kr219.17M, a decrease of -18.98% from the previous quarter. DE:8F8 total liabilities were kr38.04M for the fiscal quarter, a -32.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.